Syensqo and Singapore start-up Allozymes have signed a memorandum of understanding to develop ‘advanced biosolutions’ for home and personal care, particularly skin care. This will combine Allozymes’ ultra-high throughput microfluidics platform for the engineering of enzymes and microbes with Syensqo’s application and market access expertise.